NRx Pharmaceuticals Inc. (NRXP)

AI Score

Unlock

1.93

0.00 (0.00%)

At close: Apr 17, 2025, 3:59 PM

1.94

0.29%

After-hours: Apr 17, 2025, 07:59 PM EDT

NRx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017
Cash & Equivalents	1.44M	1.65M	1.9M	1.32M	4.59M	8.9M	14.97M	16.51M	20.05M	18.25M	24.55M	40.2M	27.61M	38.88M	13.39M	232.00	1.86M	1.29K	7.00	-877.42	877.42	194.28K	1.39K	1.82K	11.08K	77.09K	139.61K	267.19K	449.37K	82.47K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.97M	5.97M	5.93M	6.24M	1.75K	32.01M	41.48M	50.06M	71.66M	70.77M	n/a	n/a	n/a	69.03B	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.97M	n/a	6M	6M	6M	32M	41M	50M	72M	71M	70M	69M	69M	69.03M	n/a
Other Long-Term Assets	349K	356K	384K	441K	431K	21K	21K	24K	21K	23K	19K	17K	15K	15.92K	12.73K	n/a	11K	-65.33K	240.25K	192.01K	5.21K	477.05K	61.45K	-342.96K	-234.03K	-238.63K	482.93K	218.28K	n/a	91.34K
Receivables	n/a	6K	6K	6K	n/a	6K	6K	6K	n/a	547K	554K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	-6K	n/a	-6K	-6K	-7K	-547K	-554K	n/a	n/a	n/a	n/a	n/a	214K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	128K	n/a	n/a	n/a	5.25M	5.74M	6.55M	n/a	n/a	n/a	n/a	n/a	n/a	1.07M	1.81K	n/a	n/a	97.59	13.75K	39.88K	48.9K	19.11K	46.73K	76.43K	67.78K	87K	n/a
Total Current Assets	3.3M	4.11M	4.88M	3.35M	6.88M	13.09M	19.79M	21.76M	25.8M	24.8M	32.41M	43.58M	32.71M	45.23M	18.53M	59.72K	2.93M	3.1K	36.8K	877.42	975.01	208.03K	41.28K	50.72K	30.19K	123.82K	216.05K	334.97K	536.38K	82.47K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	349K	356K	384K	441K	431K	21K	21K	24K	21K	23K	19K	17K	15K	15.92K	12.73K	5.97M	11K	5.93M	6.24M	6.19M	32.01M	41.48M	50.06M	71.66M	70.77M	69.76M	69.48M	69.22M	69.03M	91.34K
Total Assets	3.65M	4.46M	5.26M	3.79M	7.32M	13.11M	19.81M	21.78M	25.82M	24.82M	32.43M	43.6M	32.73M	45.25M	18.55M	6.03M	2.94M	6.03M	6.28M	6.27M	32.07M	41.69M	50.1M	71.71M	70.8M	69.89M	69.7M	69.55M	69.57M	173.81K
Account Payables	4.13M	4.87M	5.01M	6.26M	4.63M	3.63M	2.21M	3.78M	2.08M	2.17M	3.08M	4.31M	3.69M	5.56M	6.27M	4.38K	3.15M	3.4K	n/a	313.24K	2.07K	537.31K	432.45K	446.37K	551.1K	327.52K	204.39K	61K	85.67K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	5.62M	7.68M	n/a	n/a	n/a	n/a	n/a	2.84M	3.15M	2.64M	-1.97M	43.96M	-2.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.57M	3.68M	8.59M	6.78M	9.16M	10.07M	12.69M	12.19M	7.7M	n/a	n/a	520K	518K	515.06K	173.69K	1.97M	249K	1.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	100K
Other Current Liabilities	10.93M	11.35M	9.6M	5.32M	4.42M	324K	6.77M	5.17M	5.81M	5.87M	4M	7.08M	7.72M	30.21M	29.03M	47.26K	n/a	42.88K	297.24K	n/a	620.37K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.5K	50K
Total Current Liabilities	21.86M	20.3M	23.66M	18.86M	19.05M	19.33M	22.62M	22.06M	15.59M	8.04M	7.08M	11.91M	11.92M	36.28M	35.47M	643.69K	46.16M	5.39K	297.24K	316.38K	2.38K	641.75K	521.15K	494.39K	567.41K	375.57K	217.45K	65.12K	93.17K	150K
Long-Term Debt	5.01M	2.98M	n/a	n/a	n/a	n/a	n/a	n/a	2.82M	n/a	n/a	n/a	n/a	n/a	512.47K	509.92K	548K	546.45K	2.35M	2.18M	1.95M	1.79M	1.59M	1.49M	690K	n/a	n/a	n/a	85.67M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.65M	n/a	-545.91K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	64.51M	64.48M	64.49M	n/a	n/a
Total Long-Term Liabilities	5.01M	2.98M	n/a	12.59M	n/a	n/a	n/a	3.78M	2.82M	5.87M	4M	7.6M	4.21M	n/a	512.47K	4.16M	548K	546.45	2.35M	2.18M	3.46K	1.79M	1.59M	1.49M	690K	64.51M	64.48M	64.49M	85.67M	n/a
Total Liabilities	26.87M	23.28M	23.66M	18.86M	19.05M	19.33M	22.62M	22.06M	18.41M	8.04M	7.08M	11.91M	11.92M	36.28M	35.98M	4.81M	46.71M	5.94K	2.65M	2.5M	5.84K	2.43M	2.11M	1.98M	1.26M	375.57K	217.45K	65.12K	64.57M	150K
Total Debt	6.58M	6.67M	8.59M	6.78M	9.16M	10.07M	12.69M	12.19M	10.53M	n/a	n/a	520K	518K	515.06K	686.17K	2.85M	797K	2.45M	2.35M	2.18M	1.95M	1.79M	1.59M	1.49M	690K	327.52M	204.39M	61M	85.67M	100K
Common Stock	15K	11K	11K	10K	84K	84K	80K	70K	67K	68K	67K	67K	59K	54.81K	48.6K	2.69K	43K	11.15	2.72K	2.72K	10.69	34.25M	43M	64.73M	64.54M	64.51M	64.48M	64.49M	2.59K	1.73K
Retained Earnings	-278.27M	-269.19M	-267.57M	-259.68M	-253.15M	-248.81M	-242.75M	-234.04M	-223M	-212.76M	-203.67M	-196.69M	-183.24M	-152.45M	-131.68M	-1.61M	-90.18M	-45.03K	493.21K	642.72K	-38.4K	384.25K	325.05K	149.03K	-38.93K	-68.07K	-96.15K	-89.55K	-105.03K	-1.19K
Comprehensive Income	n/a	n/a	-3K	-3K	-3K	-22K	-22K	106K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.69K	n/a	0.00	n/a	-645.43K	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-23.22M	-18.82M	-18.39M	-15.07M	-11.73M	-6.22M	-2.81M	-284K	7.41M	16.78M	25.35M	31.69M	20.81M	8.97M	-17.44M	1.22M	-43.77M	-2.83K	3.63M	-4.85K	-4.85K	39.25M	47.99M	69.73M	69.54M	69.51M	69.48M	69.49M	5M	23.81K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.97M	5.97M	11.93M	12.24M	1.75K	64.01M	82.48M	100.06M	143.66M	141.77M	70M	69M	69M	69.1B	n/a